Search research articles
Contact Us
Filters
Showing results (71-80 of 282) with videos related to
Page
of 29
Sort By:
International Journal of Cancer
|
March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses
O Manzke, H Tesch, J Lorenzen, et al.
Bone Marrow Transplantation
|
August 10, 2000
Treatment of patients with malignant lymphomas with monoclonal antibodies
H Tesch, A Engert, O Manzke, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
March 15, 1994
[Chronic fatigue syndrome]
S Schmitz, H Tesch, H Bohlen, et al.
Blut
|
June 1, 1989
Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22)
G Gradl, H Tesch, G Schwieder, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 20, 2006
Treatment of tissue sections for in situ hybridization
Gregory H Tesch, Hui Y Lan, David J Nikolic-Paterson
Annals of Hematology
|
May 10, 2000
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease
H Bohlen, M Kessler, M Sextro, et al.
Virology
|
February 13, 2001
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway
M Vockerodt, B Haier, P Buttgereit, et al.
European Journal of Immunology
|
February 1, 1993
Evidence for a human IgG1 class switch program
J Irsch, R Hendriks, H Tesch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1991
DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias
S Kochanek, A Radbruch, H Tesch, et al.
Leukemia Research
|
January 1, 1990
High affinity IL-2 receptors on a Hodgkin's derived cell line
H Tesch, T Herrmann, H Abts, et al.
Page
of 29
Search research articles
Search
Showing results (71-80 of 282) with videos related to
Sort By:
Page
of 29
International Journal of Cancer
|
March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses
O Manzke, H Tesch, J Lorenzen, et al.
Bone Marrow Transplantation
|
August 10, 2000
Treatment of patients with malignant lymphomas with monoclonal antibodies
H Tesch, A Engert, O Manzke, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
March 15, 1994
[Chronic fatigue syndrome]
S Schmitz, H Tesch, H Bohlen, et al.
Blut
|
June 1, 1989
Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22)
G Gradl, H Tesch, G Schwieder, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 20, 2006
Treatment of tissue sections for in situ hybridization
Gregory H Tesch, Hui Y Lan, David J Nikolic-Paterson
Annals of Hematology
|
May 10, 2000
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease
H Bohlen, M Kessler, M Sextro, et al.
Virology
|
February 13, 2001
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway
M Vockerodt, B Haier, P Buttgereit, et al.
European Journal of Immunology
|
February 1, 1993
Evidence for a human IgG1 class switch program
J Irsch, R Hendriks, H Tesch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1991
DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias
S Kochanek, A Radbruch, H Tesch, et al.
Leukemia Research
|
January 1, 1990
High affinity IL-2 receptors on a Hodgkin's derived cell line
H Tesch, T Herrmann, H Abts, et al.
Page
of 29